查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1308687

到 2030 年全球血糖監測市場預測 - 按類型、技術、應用、最終用戶和地區進行分析

Blood Glucose Test Strips Market Forecasts to 2030 - Global Analysis By Type, Technology (Glucose Dehydrogenase and Glucose Oxidase ), Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 175+ Pages | 商品交期: 2-3個工作天內

價格

據Stratistics MRC預計，2023年全球血糖監測條市場規模將達到144.1億美元，預計預測期內復合年增長率為8.2%，到2030年達到250.2億美元。

薄紙或塑料條（稱為血糖條）用於檢查血糖水平和管理糖尿病。這些試紙條上塗有葡萄糖氧化□，它與血液中的葡萄糖發生反應，從而顯示血糖水平。糖尿病患者可以定期監測血糖，而無需去診所或診斷實驗室。血糖試紙價格實惠，使用方便，適合日常使用。

據國際糖尿病聯盟（IDF）預測，2021年成人糖尿病患者人數約為5.37億，預計2030年將增加6.43億。

市場動態：

促進者

個人可支配收入增加

糖尿病患病率的上升是預計推動全球血糖監測條市場增長的主要因素之一。患者更喜歡使用個人血糖儀，因為它們易於使用。糖尿病患者的長期健康和慢性糖尿病並發症的一級預防都依賴於嚴格的血糖控制。指導糖尿病患者如何將每日毛細血管血糖水平控制在所需範圍內。醫生經常使用血糖儀來監測危重病人，糖尿病患者也經常使用血糖儀來自我管理疾病。血糖儀也在不斷改進，使其更易於使用、更有效。

制約因素：

缺乏意識

血糖試紙市場可能會面臨諸如患者不了解改進試紙的好處、臨床需求未得到滿足以及缺乏外部資金等挑戰，所有這些都可能會阻礙增長，特別是在新興市場，從而限制市場擴張。

機會：

醫療保健支出增加和城市化進程加快

血糖試紙比人工胰腺系統更可靠、更便宜，儘管取得了許多技術突破，但仍在使用。預計有助於全球血糖試紙市場增長的其他因素包括醫療保健成本上升、人口老齡化、消費者對血糖試紙意識的提高、政府舉措的增加以及新興經濟體日本可支配收入的增加。此外，由於城市化進程的加快以及久坐生活方式的人口不斷增加，預計該市場將會增長。

威脅

成本高、監管嚴格

嚴格的監管要求可能會阻礙增長，而高昂的治療成本預計將在預測期內嚴重限制血糖監測條的市場擴張。此外，與更傳統的葡萄糖測試方法相比，由於設備成本較高，預計市場將面臨挑戰。

COVID-19 的影響：

在 COVID-19 大流行期間，血糖監測設備的使用有所增加，這影響了對試紙的需求。COVID-19大流行期間，血糖監測設備和試紙等耗材的需求和在線銷售大幅增加。這可能是由於對患者和普通人群持續監測血糖水平的需求不斷增長，以記錄感染後症狀並作為預防措施，從而推動市場增長。

預計 2 型糖尿病細分市場在預測期內將是最大的細分市場：

預計 2 型糖尿病細分市場將在預測期內獲得較大的市場份額。2 型糖尿病患者必須監測血糖水平，以防止進一步的並發症，因為久坐的生活方式導致他們的血糖水平不受控制。根據美國疾病控制與預防中心 (CDC) 的數據，2 型糖尿病佔成人診斷糖尿病病例的 90-95%。近 10% 的女性在產後不久就被診斷出患有 2 型糖尿病，其餘女性則在 10-20 年後以 35-60% 的機率患上 2 型糖尿病。由於上述因素，全球範圍內對血糖試紙的需求大幅增加。

預計醫院領域在預測期內復合年增長率最高：

預計醫院部門在預測期內將呈現最高增長率。在醫院使用血糖儀套件可以減少辦公時間，因為這些測試比傳統的實驗室測試更快地提供結果。SMBG 裝置是一種侵入性較小、痛苦較小的手術，特別是對於不喜歡注射器靜脈穿刺或有恐血症的患者。此外，一些患者更願意去醫院由合格的醫療專業人員檢查血糖水平，這種偏好正在推動這一市場的擴張。

佔比最大的地區：

由於注重健康的人口比例較高且醫療保健行業完善，預計北美地區將佔據較大的市場份額。在北美，由於政府積極努力抗擊糖尿病以及企業投資提高糖尿病研發效率，預計未來增長。目前北美有超過 2900 萬糖尿病患者，預計到 2025 年這一數字將增至 3200 萬。此外，該地區重要市場參與者的存在是預測期內北美血糖監測條市場增長的主要驅動力。

複合年增長率最高的地區：

由於對有效治療的需求不斷增長，預計亞太地區在預測期內將成為血糖監測條的新興市場。這一增長主要是由於該地區糖尿病患病率迅速上升，預計到 2030 年印度將出現 9290 萬例糖尿病。此外，該地區不斷增長的糖尿病人口以及人們對糖尿病管理意識的不斷增強也推動了這一增長。

重大發展

2022 年 11 月，全球糖尿病護理公司、CONTOUR(R) 血糖監測 (BGM) 系統的投資組合製造商和 Eversense(R) 連續血糖監測 (CGM) 系統的經銷商 Ascensia Diabetes Care 宣布 Eversense(R) CGM 應用程序已在全球範圍內更新，可與Apple HealthTM 無縫集成。使用 Eversense CGM 系統的糖尿病患者現在可以在 Apple Health 應用程序中查看他們的血糖數據，以及來自 iPhone 上流行的健康和福祉平台的其他健康指標。

2022 年11 月，Senseonics 和Ascensia 宣佈設立一名護士，旨在通過為Eversense(R) E3 連續血糖監測系統(CGM) 提供辦公室和家庭插入選項來擴大患者接觸範圍。 □宣布與Practitioner Group 建立合作夥伴關係。

2022 年 3 月，加拿大衛生部宣布對健康網絡系統 (HNS) 關於安大略省藥物福利 (ODB) 計劃中血糖試紙報銷的變更。HNS 將根據符合 ODB 資格的患者提交的在線索賠和文件，對血糖試紙實行年度最大數量限制。

報告內容

  • 區域和國家層面的市場份額評估
  • 對新進入者的戰略建議
  • 涵蓋2021年、2022年、2023年、2026年和2030年的市場數據
  • 市場趨勢（市場驅動因素/制約因素/機會/威脅/挑戰/投資機會/建議）
  • 根據市場預測提出關鍵業務領域的戰略建議
  • 競爭格局映射關鍵共同趨勢
  • 公司概況，包括詳細戰略、財務狀況和近期發展
  • 映射最新技術進步的供應鏈趨勢

免費定制服務：

訂閱此報告的客戶將獲得以下免費定制選項之一：

  • 公司簡介
    • 其他市場參與者的綜合分析（最多 3 家公司）
    • 主要公司的SWOT分析（最多3家公司）
  • 地理細分
    • 根據客戶興趣對主要國家的市場估計/預測/複合年增長率（注：通過可行性檢查）
  • 競爭標桿
    • 根據產品組合、地域分佈和戰略聯盟對主要參與者進行基準測試

目錄

第一章內容提要

第二章前言

  • 概述
  • 利益相關者
  • 調查範圍
  • 調查方法
    • 數據挖掘
    • 數據分析
    • 數據驗證
    • 研究方法
  • 研究來源

第三章市場趨勢分析

  • 促進者
  • 抑製劑
  • 機會
  • 威脅
  • 技術分析
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • 新型冠狀病毒病（COVID-19）的影響

第4章波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭對手之間的競爭

5 全球血糖試紙市場，按類型

  • 厚電化學膜
  • 薄膜電化學
  • 燈帶
  • 其他類型

6.按技術劃分的全球血糖試紙市場

  • 葡萄糖脫氫□（GDH）
  • 葡萄糖氧化□（GOD）

7 全球血糖試紙市場，按應用

  • 1型糖尿病
  • 2型糖尿病
  • 妊娠糖尿病
  • 糖尿病前期

8 全球血糖試紙市場，按最終用戶劃分

  • 個人
  • 醫院
  • 診所和診斷中心
  • 其他最終用戶

9.全球血糖試紙市場，按地區

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 意大利
    • 法國
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳大利亞
    • 新西蘭
    • 韓國
    • 亞太其他地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美洲
  • 中東和非洲
    • 沙特阿拉伯
    • 阿拉伯聯合酋長國
    • 卡塔爾
    • 南非
    • 其他中東和非洲

第 10 章主要進展

  • 協議、夥伴關係、合作和合資企業
  • 收購與合併
  • 新產品發布
  • 業務拓展
  • 其他關鍵策略

第十一章公司簡介

  • Abbott Diabetes Care.
  • ACON Laboratories Inc.
  • Agamatrix Inc.
  • Arkray Inc.
  • Ascensia Diabetes Care
  • Bayer Diabetes Care
  • Bionime Corporation
  • Elektronika
  • i-SENS
  • Johnson & Johnson
  • LifeScan IP Holdings LLC
  • Nipro Diagnostics
  • Roche Diagnostics
  • Rossmax International Ltd
  • TaiDoc
  • Trividia Health Inc.
  • Universal Biosensors
Product Code: SMRC23387

According to Stratistics MRC, the Global Blood Glucose Test Strips Market is accounted for $14.41 billion in 2023 and is expected to reach $25.02 billion by 2030 growing at a CAGR of 8.2% during the forecast period. Thin paper or plastic strips called blood glucose test strips are used to check blood glucose levels and help manage diabetes. The strips are covered in glucose oxidase, which reacts with the blood's glucose to reveal the blood sugar level. These are used by diabetics to monitor their blood glucose levels on a regular basis without having to go to a clinic or a diagnostic lab. In addition, blood glucose test strips are affordable, simple to use, and suitable for daily use.

According to International Diabetes Federation (IDF), the adult diabetes population in 2021 was approximately 537 million, which is expected to increase by 643 million in 2030.

Market Dynamics:

Driver:

Rising personal disposable income

The rising prevalence of diabetes is one of the main factors anticipated to propel market growth for blood glucose test strips worldwide. Patients prefer to use glucometers for personal use because they are simple to use. The long-term health of diabetics and the primary prevention of chronic diabetic complications both depend on strict glucose control. Patients with diabetes are taught how to manage their daily capillary glucose levels in order to keep them within desired ranges. Blood glucose meters are frequently used by doctors to monitor critically ill patients as well as by diabetic patients to self-manage their disease. Glucometers are also continually upgraded for easier use and greater effectiveness.

Restraint:

Lack of awareness

The blood glucose test strip market is likely to face challenges due to patient ignorance of the benefits of improved test strips, unmet clinical needs, and a lack of external funding, which are all limiting market expansion, particularly in developing nations.

Opportunity:

Increasing healthcare expenditure and growing urbanization

Blood glucose test strips are still used as they are more reliable and affordable than artificial pancreas systems, despite numerous groundbreaking technological developments that are focused on them. Other factors that are anticipated to contribute to the growth of the global blood glucose test strips market include rising healthcare costs, an aging population, increased consumer awareness of blood glucose test strips, increased government initiatives, and rising disposable income in emerging economies. Additionally, the market is expected to grow as a result of increasing urbanization and an ever-growing population that is leading a more sedentary lifestyle.

Threat:

High costs and strict regulations

Strict regulatory requirements could impede growth, and high treatment costs are anticipated to limit market expansion for blood glucose test strips to a large extent during the forecast period. Additionally, the market is anticipated to face challenges due to the high cost of the device when compared to more traditional glucose testing methods.

COVID-19 Impact:

The use of blood glucose monitoring equipment has increased during the COVID-19 pandemic, which has affected the demand for test strips. During the COVID-19 pandemic, the demand for and online sales of blood glucose monitoring equipment and supplies, such as test strips, significantly increased. This can be attributed to the rising demand for continuous monitoring of sugar levels in patients and the general population in order to record post-infection symptoms and act as a preventative measure, which is augmenting market growth.

The type 2 diabetes segment is expected to be the largest during the forecast period:

During the anticipated period, the type 2 diabetes segment is anticipated to gain significant market share. Patients with Type-2 diabetes must monitor their blood sugar levels to prevent further complications because their blood glucose levels are out of control as a result of their sedentary lifestyles. According to the Centers for Disease Control and Prevention (CDC), type 2 diabetes makes up 90 to 95% of all diagnosed cases of diabetes in adults. Nearly 10% of women have type 2 diabetes identified soon after birth; the remaining women have a 35 to 60% chance of developing the disease over the following 10 to 20 years. The aforementioned factor's has led to a significant increase in blood glucose test strip demand worldwide.

The hospitals segment is expected to have the highest CAGR during the forecast period:

The hospitals segment is anticipated to witness the highest growth rate during the forecasted period. Since these tests yield results more quickly than traditional laboratory tests, the use of glucose meter kits in hospitals speeds up operational times. SMBG devices are a convenient method, especially for patients who prefer not to use venipuncture methods through syringes or who have hemophobia, as they are minimally invasive and less painful for patients. Additionally, some patients favor visiting hospitals to have their blood sugar levels checked by qualified medical professionals, and this preference is fueling the expansion of this market.

Region with largest share:

Owing to its large proportion of health-conscious people and established healthcare industry, the North American region is anticipated to hold a significant market share. North America has a lot of potential for growth in the future due to increased government efforts to combat diabetes and corporate investments to streamline diabetes R&D. In North America, there are currently over 29 million diabetics, and by 2025, that number is expected to rise to 32 million. Additionally, the presence of significant market players in the area has been a major driver of the growth of the blood glucose test strip market in North America over the forecast period.

Region with highest CAGR:

Due to the region's increasing need for efficient therapeutic treatment, Asia Pacific is anticipated to be an emerging market for blood glucose test strips during the forecasted period. This growth is primarily the result of the rapidly rising prevalence of diabetes in the area; by 2030, India is expected to have 92.9 million cases. Additionally, the growth is being fueled by the region's rising diabetic population and growing awareness of diabetes management.

Key players in the market

Some of the key players profiled in the Blood Glucose Test Strips Market include Abbott Diabetes Care, ACON Laboratories Inc., Agamatrix Inc., Arkray Inc., Ascensia Diabetes Care, Bayer Diabetes Care, Bionime Corporation, Elektronika, i-SENS, Johnson & Johnson, LifeScan IP Holdings LLC, Nipro Diagnostics, Roche Diagnostics, Rossmax International Ltd, TaiDoc, Trividia Health Inc. and Universal Biosensors.

Key Developments:

In November 2022, Ascensia Diabetes Care, a global diabetes care company, maker of the CONTOUR® Blood Glucose Monitoring (BGM) System portfolio and distributor of the Eversense® Continuous Glucose Monitoring (CGM) System, announces that the Eversense® CGM app has been updated globally to seamlessly integrate with Apple HealthTM. This means that people with diabetes using Eversense CGM Systems will now also have the option to view their glucose data within the Apple Health app, alongside other health metrics on the iPhone's widely used health and wellbeing platform.

In November 2022, Senseonics and Ascensia Announce a Collaboration with the Nurse Practitioner Group Designed to Expand Patient Access by Providing In-Office and At-Home Insertion Options for Eversense® E3 Continuous Glucose Monitoring System (CGM).

In March 2022, Ministry of Health Canada released Health Network System (HNS) changes to reimbursement of blood glucose test strips under the Ontario Drug Benefit (ODB) Program. The HNS will apply the blood glucose test strip's annual maximum quantity limit based on online claims and papers submitted for reimbursement by ODB-eligible patients.

Types Covered:

  • Thick Film Electrochemical Films
  • Thin Film Electrochemical
  • Optical Strips
  • Other Types

Technologies Covered:

  • Glucose Dehydrogenase (GDH)
  • Glucose Oxidase (GOD)

Applications Covered:

  • Type 1 Diabetes
  • Type 2 Diabetes
  • Gestational Diabetes
  • Pre-Diabetes

End Users Covered:

  • Individuals
  • Hospitals
  • Clinics & Diagnostic Centers
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026 and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Technology Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Blood Glucose Test Strips Market, By Type

  • 5.1 Introduction
  • 5.2 Thick Film Electrochemical Films
  • 5.3 Thin Film Electrochemical
  • 5.4 Optical Strips
  • 5.5 Other Types

6 Global Blood Glucose Test Strips Market, By Technology

  • 6.1 Introduction
  • 6.2 Glucose Dehydrogenase (GDH)
  • 6.3 Glucose Oxidase (GOD)

7 Global Blood Glucose Test Strips Market, By Application

  • 7.1 Introduction
  • 7.2 Type 1 Diabetes
  • 7.3 Type 2 Diabetes
  • 7.4 Gestational Diabetes
  • 7.5 Pre-Diabetes

8 Global Blood Glucose Test Strips Market, By End User

  • 8.1 Introduction
  • 8.2 Individuals
  • 8.3 Hospitals
  • 8.4 Clinics & Diagnostic Centers
  • 8.5 Other End Users

9 Global Blood Glucose Test Strips Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Abbott Diabetes Care.
  • 11.2 ACON Laboratories Inc.
  • 11.3 Agamatrix Inc.
  • 11.4 Arkray Inc.
  • 11.5 Ascensia Diabetes Care
  • 11.6 Bayer Diabetes Care
  • 11.7 Bionime Corporation
  • 11.8 Elektronika
  • 11.9 i-SENS
  • 11.10 Johnson & Johnson
  • 11.11 LifeScan IP Holdings LLC
  • 11.12 Nipro Diagnostics
  • 11.13 Roche Diagnostics
  • 11.14 Rossmax International Ltd
  • 11.15 TaiDoc
  • 11.16 Trividia Health Inc.
  • 11.17 Universal Biosensors

List of Tables

  • Table 1 Global Blood Glucose Test Strips Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Blood Glucose Test Strips Market Outlook, By Type (2021-2030) ($MN)
  • Table 3 Global Blood Glucose Test Strips Market Outlook, By Thick Film Electrochemical Films (2021-2030) ($MN)
  • Table 4 Global Blood Glucose Test Strips Market Outlook, By Thin Film Electrochemical (2021-2030) ($MN)
  • Table 5 Global Blood Glucose Test Strips Market Outlook, By Optical Strips (2021-2030) ($MN)
  • Table 6 Global Blood Glucose Test Strips Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 7 Global Blood Glucose Test Strips Market Outlook, By Technology (2021-2030) ($MN)
  • Table 8 Global Blood Glucose Test Strips Market Outlook, By Glucose Dehydrogenase (GDH) (2021-2030) ($MN)
  • Table 9 Global Blood Glucose Test Strips Market Outlook, By Glucose Oxidase (GOD) (2021-2030) ($MN)
  • Table 10 Global Blood Glucose Test Strips Market Outlook, By Application (2021-2030) ($MN)
  • Table 11 Global Blood Glucose Test Strips Market Outlook, By Type 1 Diabetes (2021-2030) ($MN)
  • Table 12 Global Blood Glucose Test Strips Market Outlook, By Type 2 Diabetes (2021-2030) ($MN)
  • Table 13 Global Blood Glucose Test Strips Market Outlook, By Gestational Diabetes (2021-2030) ($MN)
  • Table 14 Global Blood Glucose Test Strips Market Outlook, By Pre-Diabetes (2021-2030) ($MN)
  • Table 15 Global Blood Glucose Test Strips Market Outlook, By End User (2021-2030) ($MN)
  • Table 16 Global Blood Glucose Test Strips Market Outlook, By Individuals (2021-2030) ($MN)
  • Table 17 Global Blood Glucose Test Strips Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 18 Global Blood Glucose Test Strips Market Outlook, By Clinics & Diagnostic Centers (2021-2030) ($MN)
  • Table 19 Global Blood Glucose Test Strips Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 20 North America Blood Glucose Test Strips Market Outlook, By Country (2021-2030) ($MN)
  • Table 21 North America Blood Glucose Test Strips Market Outlook, By Type (2021-2030) ($MN)
  • Table 22 North America Blood Glucose Test Strips Market Outlook, By Thick Film Electrochemical Films (2021-2030) ($MN)
  • Table 23 North America Blood Glucose Test Strips Market Outlook, By Thin Film Electrochemical (2021-2030) ($MN)
  • Table 24 North America Blood Glucose Test Strips Market Outlook, By Optical Strips (2021-2030) ($MN)
  • Table 25 North America Blood Glucose Test Strips Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 26 North America Blood Glucose Test Strips Market Outlook, By Technology (2021-2030) ($MN)
  • Table 27 North America Blood Glucose Test Strips Market Outlook, By Glucose Dehydrogenase (GDH) (2021-2030) ($MN)
  • Table 28 North America Blood Glucose Test Strips Market Outlook, By Glucose Oxidase (GOD) (2021-2030) ($MN)
  • Table 29 North America Blood Glucose Test Strips Market Outlook, By Application (2021-2030) ($MN)
  • Table 30 North America Blood Glucose Test Strips Market Outlook, By Type 1 Diabetes (2021-2030) ($MN)
  • Table 31 North America Blood Glucose Test Strips Market Outlook, By Type 2 Diabetes (2021-2030) ($MN)
  • Table 32 North America Blood Glucose Test Strips Market Outlook, By Gestational Diabetes (2021-2030) ($MN)
  • Table 33 North America Blood Glucose Test Strips Market Outlook, By Pre-Diabetes (2021-2030) ($MN)
  • Table 34 North America Blood Glucose Test Strips Market Outlook, By End User (2021-2030) ($MN)
  • Table 35 North America Blood Glucose Test Strips Market Outlook, By Individuals (2021-2030) ($MN)
  • Table 36 North America Blood Glucose Test Strips Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 37 North America Blood Glucose Test Strips Market Outlook, By Clinics & Diagnostic Centers (2021-2030) ($MN)
  • Table 38 North America Blood Glucose Test Strips Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 39 Europe Blood Glucose Test Strips Market Outlook, By Country (2021-2030) ($MN)
  • Table 40 Europe Blood Glucose Test Strips Market Outlook, By Type (2021-2030) ($MN)
  • Table 41 Europe Blood Glucose Test Strips Market Outlook, By Thick Film Electrochemical Films (2021-2030) ($MN)
  • Table 42 Europe Blood Glucose Test Strips Market Outlook, By Thin Film Electrochemical (2021-2030) ($MN)
  • Table 43 Europe Blood Glucose Test Strips Market Outlook, By Optical Strips (2021-2030) ($MN)
  • Table 44 Europe Blood Glucose Test Strips Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 45 Europe Blood Glucose Test Strips Market Outlook, By Technology (2021-2030) ($MN)
  • Table 46 Europe Blood Glucose Test Strips Market Outlook, By Glucose Dehydrogenase (GDH) (2021-2030) ($MN)
  • Table 47 Europe Blood Glucose Test Strips Market Outlook, By Glucose Oxidase (GOD) (2021-2030) ($MN)
  • Table 48 Europe Blood Glucose Test Strips Market Outlook, By Application (2021-2030) ($MN)
  • Table 49 Europe Blood Glucose Test Strips Market Outlook, By Type 1 Diabetes (2021-2030) ($MN)
  • Table 50 Europe Blood Glucose Test Strips Market Outlook, By Type 2 Diabetes (2021-2030) ($MN)
  • Table 51 Europe Blood Glucose Test Strips Market Outlook, By Gestational Diabetes (2021-2030) ($MN)
  • Table 52 Europe Blood Glucose Test Strips Market Outlook, By Pre-Diabetes (2021-2030) ($MN)
  • Table 53 Europe Blood Glucose Test Strips Market Outlook, By End User (2021-2030) ($MN)
  • Table 54 Europe Blood Glucose Test Strips Market Outlook, By Individuals (2021-2030) ($MN)
  • Table 55 Europe Blood Glucose Test Strips Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 56 Europe Blood Glucose Test Strips Market Outlook, By Clinics & Diagnostic Centers (2021-2030) ($MN)
  • Table 57 Europe Blood Glucose Test Strips Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 58 Asia Pacific Blood Glucose Test Strips Market Outlook, By Country (2021-2030) ($MN)
  • Table 59 Asia Pacific Blood Glucose Test Strips Market Outlook, By Type (2021-2030) ($MN)
  • Table 60 Asia Pacific Blood Glucose Test Strips Market Outlook, By Thick Film Electrochemical Films (2021-2030) ($MN)
  • Table 61 Asia Pacific Blood Glucose Test Strips Market Outlook, By Thin Film Electrochemical (2021-2030) ($MN)
  • Table 62 Asia Pacific Blood Glucose Test Strips Market Outlook, By Optical Strips (2021-2030) ($MN)
  • Table 63 Asia Pacific Blood Glucose Test Strips Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 64 Asia Pacific Blood Glucose Test Strips Market Outlook, By Technology (2021-2030) ($MN)
  • Table 65 Asia Pacific Blood Glucose Test Strips Market Outlook, By Glucose Dehydrogenase (GDH) (2021-2030) ($MN)
  • Table 66 Asia Pacific Blood Glucose Test Strips Market Outlook, By Glucose Oxidase (GOD) (2021-2030) ($MN)
  • Table 67 Asia Pacific Blood Glucose Test Strips Market Outlook, By Application (2021-2030) ($MN)
  • Table 68 Asia Pacific Blood Glucose Test Strips Market Outlook, By Type 1 Diabetes (2021-2030) ($MN)
  • Table 69 Asia Pacific Blood Glucose Test Strips Market Outlook, By Type 2 Diabetes (2021-2030) ($MN)
  • Table 70 Asia Pacific Blood Glucose Test Strips Market Outlook, By Gestational Diabetes (2021-2030) ($MN)
  • Table 71 Asia Pacific Blood Glucose Test Strips Market Outlook, By Pre-Diabetes (2021-2030) ($MN)
  • Table 72 Asia Pacific Blood Glucose Test Strips Market Outlook, By End User (2021-2030) ($MN)
  • Table 73 Asia Pacific Blood Glucose Test Strips Market Outlook, By Individuals (2021-2030) ($MN)
  • Table 74 Asia Pacific Blood Glucose Test Strips Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 75 Asia Pacific Blood Glucose Test Strips Market Outlook, By Clinics & Diagnostic Centers (2021-2030) ($MN)
  • Table 76 Asia Pacific Blood Glucose Test Strips Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 77 South America Blood Glucose Test Strips Market Outlook, By Country (2021-2030) ($MN)
  • Table 78 South America Blood Glucose Test Strips Market Outlook, By Type (2021-2030) ($MN)
  • Table 79 South America Blood Glucose Test Strips Market Outlook, By Thick Film Electrochemical Films (2021-2030) ($MN)
  • Table 80 South America Blood Glucose Test Strips Market Outlook, By Thin Film Electrochemical (2021-2030) ($MN)
  • Table 81 South America Blood Glucose Test Strips Market Outlook, By Optical Strips (2021-2030) ($MN)
  • Table 82 South America Blood Glucose Test Strips Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 83 South America Blood Glucose Test Strips Market Outlook, By Technology (2021-2030) ($MN)
  • Table 84 South America Blood Glucose Test Strips Market Outlook, By Glucose Dehydrogenase (GDH) (2021-2030) ($MN)
  • Table 85 South America Blood Glucose Test Strips Market Outlook, By Glucose Oxidase (GOD) (2021-2030) ($MN)
  • Table 86 South America Blood Glucose Test Strips Market Outlook, By Application (2021-2030) ($MN)
  • Table 87 South America Blood Glucose Test Strips Market Outlook, By Type 1 Diabetes (2021-2030) ($MN)
  • Table 88 South America Blood Glucose Test Strips Market Outlook, By Type 2 Diabetes (2021-2030) ($MN)
  • Table 89 South America Blood Glucose Test Strips Market Outlook, By Gestational Diabetes (2021-2030) ($MN)
  • Table 90 South America Blood Glucose Test Strips Market Outlook, By Pre-Diabetes (2021-2030) ($MN)
  • Table 91 South America Blood Glucose Test Strips Market Outlook, By End User (2021-2030) ($MN)
  • Table 92 South America Blood Glucose Test Strips Market Outlook, By Individuals (2021-2030) ($MN)
  • Table 93 South America Blood Glucose Test Strips Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 94 South America Blood Glucose Test Strips Market Outlook, By Clinics & Diagnostic Centers (2021-2030) ($MN)
  • Table 95 South America Blood Glucose Test Strips Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 96 Middle East & Africa Blood Glucose Test Strips Market Outlook, By Country (2021-2030) ($MN)
  • Table 97 Middle East & Africa Blood Glucose Test Strips Market Outlook, By Type (2021-2030) ($MN)
  • Table 98 Middle East & Africa Blood Glucose Test Strips Market Outlook, By Thick Film Electrochemical Films (2021-2030) ($MN)
  • Table 99 Middle East & Africa Blood Glucose Test Strips Market Outlook, By Thin Film Electrochemical (2021-2030) ($MN)
  • Table 100 Middle East & Africa Blood Glucose Test Strips Market Outlook, By Optical Strips (2021-2030) ($MN)
  • Table 101 Middle East & Africa Blood Glucose Test Strips Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 102 Middle East & Africa Blood Glucose Test Strips Market Outlook, By Technology (2021-2030) ($MN)
  • Table 103 Middle East & Africa Blood Glucose Test Strips Market Outlook, By Glucose Dehydrogenase (GDH) (2021-2030) ($MN)
  • Table 104 Middle East & Africa Blood Glucose Test Strips Market Outlook, By Glucose Oxidase (GOD) (2021-2030) ($MN)
  • Table 105 Middle East & Africa Blood Glucose Test Strips Market Outlook, By Application (2021-2030) ($MN)
  • Table 106 Middle East & Africa Blood Glucose Test Strips Market Outlook, By Type 1 Diabetes (2021-2030) ($MN)
  • Table 107 Middle East & Africa Blood Glucose Test Strips Market Outlook, By Type 2 Diabetes (2021-2030) ($MN)
  • Table 108 Middle East & Africa Blood Glucose Test Strips Market Outlook, By Gestational Diabetes (2021-2030) ($MN)
  • Table 109 Middle East & Africa Blood Glucose Test Strips Market Outlook, By Pre-Diabetes (2021-2030) ($MN)
  • Table 110 Middle East & Africa Blood Glucose Test Strips Market Outlook, By End User (2021-2030) ($MN)
  • Table 111 Middle East & Africa Blood Glucose Test Strips Market Outlook, By Individuals (2021-2030) ($MN)
  • Table 112 Middle East & Africa Blood Glucose Test Strips Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 113 Middle East & Africa Blood Glucose Test Strips Market Outlook, By Clinics & Diagnostic Centers (2021-2030) ($MN)
  • Table 114 Middle East & Africa Blood Glucose Test Strips Market Outlook, By Other End Users (2021-2030) ($MN)